NADROPARIN belongs to the class of ‘anticoagulants’ (blood thinners), primarily used to prevent and treat harmful blood clots. NADROPARIN is also used to prevent stroke or heart attack and deep vein thrombosis (blood clots in leg veins). It reduces the risk of blood clots in patients undergoing larger orthopaedic surgeries like elective hip surgeries. A blood clot can occur in any part of the body, leading to a heart attack, stroke and damage to organs (even coma or death). Blood clots can reach the arteries or veins in the organs like the brain, kidney, heart, lungs and limbs.
NADROPARIN contains ‘Nadroparin’ that belongs to the class of low molecular weight heparins (LMWHs). It works by inhibiting the production of clotting factors. This further prevents the conversion of fibrinogen (soluble protein) to fibrin (insoluble protein), thereby preventing blood clot formation. NADROPARIN helps in the free flow of blood through your veins, making it less likely to form a serious blood clot.
NADROPARIN will be administered by a healthcare professional, do not self-administer. Your doctor will advise the dosage and duration of NADROPARIN based on your medical condition. The common side effects of NADROPARIN include easy bruising, injection site pain and swelling, mild irritation, weakness, numbness, dizziness, headache, and confusion. Most of these side effects of NADROPARIN do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
Do not stop taking NADROPARIN abruptly since it may worsen your condition and increase the risk of a future heart attack. Let your doctor know if you are allergic to NADROPARIN or have kidney/liver diseases and active bleeding issues (like peptic ulcer, brain haemorrhage). NADROPARIN is not recommended for use during pregnancy and breastfeeding; however, please seek medical advice. The patient should inform the doctor that they are taking NADROPARIN before any surgery is scheduled or any new medicine is taken. Please stay away from activities that may increase your risk of bleeding, like contact sports and using sharp objects like razors and nail cutters.
Prevention of blood clots.
NADROPARIN is composed of Nadroparin, an anticoagulant or a blood thinner. It is low molecular weight heparin and prevents the formation of blood clots by inhibiting the production of clotting factors. It also reduces the risk of blood clots in patients undergoing larger orthopaedic surgeries like elective hip surgeries. NADROPARIN helps in the free flow of blood, thereby preventing the risk of heart attack, stroke, deep vein thrombosis (blood clot in the vein), and pulmonary embolism (blood clots in the arteries of lungs). NADROPARIN is used to prevent blood clotting in extracorporeal circulation (apparatus carrying the blood outside the body) during haemodialysis (purifying blood in a person whose kidney are abnormally functioning) and hemofiltration (renal replacement therapy) processes.
Before taking NADROPARIN, let your doctor know if you have a history of liver and kidney diseases or allergic reactions to NADROPARIN. Inform your doctor beforehand if you have a risk of internal bleeding (stomach ulcer), blood disorders (bleeding inside any tissues, organs or joints of your body), a recent injury/surgery or a planned surgery (including dental) in the next few days, a clot in an artery of your brain (ischaemic stroke), eye problems like diabetic retinopathy, spinal problems, artificial heart valves, and high blood pressure. NADROPARIN is not recommended for use during pregnancy and breastfeeding; however, please seek medical advice. Try avoiding alcohol to prevent any side effects’ occurrence further. If you experience dizziness, do not drive or operate machinery. NADROPARIN is not recommended in people younger than 18 years of age. Store NADROPARIN at temperatures not exceeding 25°C.
Drug-Drug Interaction: NADROPARIN may interact with other blood thinners (clopidogrel, ticlopidine), pain killers, corticosteroids, abortion drugs (mifepristone), and blood pressure medicines (benazepril, captopril).
Drug-Food Interaction: Limit alcohol intake since it may cause a rise in blood pressure leading to heart diseases. Avoid fatty foods and control your cholesterol and triglyceride levels.
Drug-Disease Interaction: Brief your doctor if you have a medical history of heart diseases, active bleeding disorders, ischaemic stroke, diabetic retinopathy, spinal problems, artificial heart valves, high blood pressure, liver, and kidney diseases before taking NADROPARIN.
It is unsafe to consume alcohol since it may worsen the side effects like dizziness and increase blood pressure.
NADROPARIN is not recommended and is probably unsafe to use during pregnancy due to limited information. Please consult your doctor if you are planning to become pregnant or already pregnant before starting NADROPARIN.
There is limited data on how NADROPARIN affects breastfeeding. However, it is probably unsafe to use and not recommended if you are lactating. Please consult your doctor before starting NADROPARIN.
Do not drive or operate machinery if you experience dizziness or drowsiness while using NADROPARIN. NADROPARIN can also sometimes cause blurry vision, hence avoid driving in such situations. Seek medical attention if the symptoms persist longer.
Let your doctor know if you have any history of liver diseases or hepatic impairment. Your doctor will weigh the benefits and potential risks before prescribing NADROPARIN.
Let your doctor know if you have any history of kidney diseases. Your doctor will weigh the benefits and potential risks before prescribing NADROPARIN.
NADROPARIN is not recommended for children below the age of 18 years. The safety and efficacy of NADROPARIN have not been established in children.
Since NADROPARIN may affect liver enzymes, your doctor may suggest liver function tests to check your aspartate aminotransferase (AST), alanine aminotransferase (ALT), and bilirubin levels before starting treatment and every two weeks after the treatment with NADROPARIN.
A blood clot is a clump of blood that has changed from liquid to gel-like or semisolid state. Blood clots are formed to stop bleeding that occurs due to tissue injury. Though blood clots are useful to stop bleeding, they may be harmful when abnormally formed within the blood vessels, restricting the blood flow to essential organs, such as the brain, heart, or lungs, resulting in severe conditions.
Deep vein thrombosis (blood clots in legs) is a medical condition in which blood clots form in deep veins, usually in the legs. The symptoms include leg pain or swelling.
A heart attack occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is often an accumulation of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). Signs of a heart attack include chest pain, upper body pain, sweating, nausea, fatigue and trouble breathing.